BORGIANI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 35.977
EU - Europa 3.306
AS - Asia 3.122
SA - Sud America 546
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 5
Totale 43.027
Nazione #
US - Stati Uniti d'America 35.874
SG - Singapore 1.604
CN - Cina 670
DE - Germania 546
IT - Italia 492
BR - Brasile 475
UA - Ucraina 451
IE - Irlanda 367
HK - Hong Kong 292
PL - Polonia 256
FR - Francia 248
GB - Regno Unito 239
RU - Federazione Russa 220
SE - Svezia 175
VN - Vietnam 155
FI - Finlandia 132
KR - Corea 91
CA - Canada 64
JP - Giappone 46
NL - Olanda 46
IN - India 44
TR - Turchia 38
BE - Belgio 32
AR - Argentina 31
KG - Kirghizistan 29
ZA - Sudafrica 29
MX - Messico 27
ID - Indonesia 26
BD - Bangladesh 23
IR - Iran 23
AT - Austria 22
CZ - Repubblica Ceca 20
UZ - Uzbekistan 17
ES - Italia 16
IQ - Iraq 13
MA - Marocco 12
EU - Europa 11
CH - Svizzera 7
CO - Colombia 7
EC - Ecuador 7
LT - Lituania 7
RO - Romania 7
A2 - ???statistics.table.value.countryCode.A2??? 6
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
PE - Perù 5
SA - Arabia Saudita 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DZ - Algeria 4
GR - Grecia 4
KZ - Kazakistan 4
LB - Libano 4
MY - Malesia 4
VE - Venezuela 4
AZ - Azerbaigian 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
NP - Nepal 3
OM - Oman 3
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IS - Islanda 2
JM - Giamaica 2
JO - Giordania 2
PA - Panama 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 43.027
Città #
Woodbridge 9.831
Wilmington 9.462
Houston 8.587
Fairfield 1.197
Singapore 811
Ann Arbor 737
Ashburn 648
Chandler 643
Seattle 432
Cambridge 389
Jacksonville 365
New York 362
Beijing 343
Dublin 339
Hong Kong 290
Medford 260
Kraków 215
Rome 205
Dearborn 159
Dallas 157
Santa Clara 143
Los Angeles 126
Lawrence 120
The Dalles 120
Boardman 109
Menlo Park 94
Council Bluffs 65
Buffalo 62
San Diego 60
São Paulo 55
Munich 54
Ho Chi Minh City 48
Hanoi 42
London 42
Moscow 42
Zhengzhou 37
Redwood City 33
Milan 32
Warsaw 32
Palo Alto 30
Chicago 28
Helsinki 27
Mülheim 26
Norwalk 26
Brussels 25
Tokyo 25
Montreal 24
Nuremberg 24
Shanghai 24
Atlanta 23
Mountain View 23
Toronto 23
Denver 22
Hefei 22
Redondo Beach 22
Johannesburg 21
Jakarta 20
Phoenix 20
Brooklyn 18
Chennai 18
Stockholm 17
University Park 17
Seoul 16
Orem 15
Poplar 15
Ankara 14
San Francisco 14
Kunming 13
Nanjing 13
Amsterdam 12
Belo Horizonte 12
Olomouc 12
Vienna 12
Detroit 11
Frankfurt am Main 11
Hangzhou 11
Brasília 10
Columbus 10
Da Nang 10
Guangzhou 10
Lappeenranta 10
Manchester 10
North Bergen 10
Querétaro 10
Verona 10
Rio de Janeiro 9
Tashkent 9
Turku 9
Boston 8
Creede 8
Dhaka 8
Istanbul 8
Nürnberg 8
Paris 8
Brno 7
Changsha 7
Curitiba 7
Elk Grove Village 7
Fortaleza 7
Haiphong 7
Totale 37.661
Nome #
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 508
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 492
High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase 489
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 478
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians 475
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 471
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 469
A family study of asymptomatic small bowel Crohn's disease 468
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 467
Advances in exploring the role of micrornas in inflammatory bowel disease 466
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population 465
Age-related macular degeneration: insights into inflammatory genes 464
A Pharmacogenetics Study in Mozambican Patients Treated with Nevirapine: Full Resequencing of TRAF3IP2 Gene Shows a Novel Association with SJS/TEN Susceptibility 464
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene 458
Intrauterine development and MNSs blood groups in repeated spontaneous abortion. 456
Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease 455
Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice 447
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study 447
Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01 446
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons syndrome/toxic epidermal necrolysis susceptibility in a population from Mozambique 445
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 445
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms 442
A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus 440
Foetal macrosomia and erythrocyte acid phosphatase (ACP1) polymorphism in diabetic and normal pregnancy. 440
Role of genetics in prevention of coronary atherosclerosis 440
Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique 439
Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient 439
Interleukin-23R Arg381Gln Is Associated With Susceptibility to Crohn's Disease But Not With Phenotype in an Italian Population 437
Crohn's disease, the mycobacterium paratuberculosis and the genetic bond: An unexpected trio 434
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 432
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction 431
Comparative analysis between saliva and buccal swabs as source of DNA: Lesson from HLA-B∗57:01 testing 428
Association of the ACP1 genotype with metabolic parameters upon initial diagnosis of type 1 diabetes. 426
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 426
FLG (filaggrin) null mutations and sunlight exposure: Evidence of a correlation 426
Pharmacogenomics of multifactorial diseases: A focus on psoriatic arthritis 425
Cannabinoid Poisoning by Hemp Seed Oil in a Child 425
Biomarkers to predict drug efficacy and safety in neurodegenerative diseases 423
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. 423
Association between ACP(1) and favism: A possible biochemical mechanism 422
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 421
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 420
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 419
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 419
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 419
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development 417
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis 416
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase 416
Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy 412
Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population 410
Phosphotyrosine-protein-phosphatase and diabetic disorders. Further studies on the relationship between low molecular weight acid phosphatase genotype and degree of glycemic control 409
Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM 409
Identification of two SNPs in the 5' flanking region of the ACP1 gene and evaluation of disequilibrium among polymorphic sites. 409
Recent advances in the genetic susceptibility to osteoarthritis 407
Neonatal screening, clinical features and genetic testing for galactosemia [3] 404
Acid phosphatase locus 1 (ACP1): Possible relationship of allelic variation to body size and human population adaptation to thermal stress - A theoretical perspective 404
Two molecular assays for the rapid and inexpensive detection of GJB2 and GJB6 mutations 403
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease 400
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 398
RH blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level? 397
EPHX1 Polymorphisms Are Not Associated With Warfarin Response in an Italian Population 396
ABCC10 rs2125739 polymorphism and nevirapine-induced hepatotoxicity: lack of association in a population from Mozambique 396
Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. 396
MicroRNA genetic variations: association with type 2 diabetes 394
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 394
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 393
Phosphoglucomutase genetic polymorphism of newborns 393
IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs 391
A study of human growth hormone and insulin gene regions in relation to metabolic control of non-insulin-dependent diabetes mellitus 390
Correction: A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics 390
Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases 388
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 383
Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction 382
Rh blood groups and diabetic disorders 382
OLR1 gene and coronary artery disease/acute myocardial infarction: Replication in an independently collected sample [1] 380
L’impatto sulla salute umana dell’arsenico presente in basse concentrazioni nelle acque. Proposta di uno studio caso controllo Nested nell’area del viterbese 377
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 377
Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes 376
Pharmacogenomics: role in medicines approval and clinical use 373
New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases [Nuovi approfondimenti nella ricerca su l'ateroslerosi: LOX-1, un primo attore nelle malattie cardiovascolari] 372
Low molecular weight PTP-IL-4RA interaction in atopy predisposition 370
Genetic tests and genomic biomarkers: regulation, qualification and validation 369
Foetal macrosomia in diabetic pregnancy. Further data on the association with maternal PGM1 genotype 357
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 355
Pharmacogenetics of inflammatory bowel disease: A focus on Crohn's disease 348
Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic Studies 347
Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility 345
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 342
Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. 330
A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine 303
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population 302
Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility 294
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 283
Interaction between microbiome and host genetics in psoriatic arthritis 267
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects 265
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes 260
Pharmacogenomics in Parkinson's disease: which perspective for developing a personalized medicine? 251
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 241
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals 235
miRNAs in drug response variability: potential utility as biomarkers for personalized medicine 191
Totale 39.960
Categoria #
all - tutte 99.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.920 0 0 0 0 0 737 847 731 159 157 220 69
2021/20221.359 75 134 60 83 52 145 67 55 125 122 104 337
2022/20231.653 171 142 47 232 158 383 142 91 137 20 85 45
2023/2024848 84 19 40 24 47 331 34 41 12 8 16 192
2024/20253.011 91 672 308 226 59 125 222 182 340 278 229 279
2025/20262.578 504 204 654 545 526 145 0 0 0 0 0 0
Totale 43.544